Expression of α2,6-sialic acid-containing and lewis-active glycolipids in several types of human ovarian carcinomas

Kyoko Tanaka, Mikio Mikami, Daisuke Aoki, Kazushige Kiguchi, Isamu Ishiwata, Masao Iwamori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

To identify glycolipid antigens associated with histologically defined types of ovarian carcinomas, we determined the amounts of α2,6-sialyl and Lewis-active glycolipids, the specific activities of the α2,3- and α2,6-sialyltransferases, and the gene expression of sugar transferases in mucinous and serous cystadenocarcinoma, clear cell adenocarcinoma and endometrioid carcinoma tissues and cell lines derived from them. α2,6-sialyl glycolipid IV6NeuAcα-nLc4Cer detected with a newly developed monoclonal antibody, Y916, was present in 5/7 serous cystadenocarcinoma cases in relatively higher amounts than those in the other carcinoma tissues. On the other hand, the amounts of Lewis-active glycolipids in serous cystadenocarcinoma tissues were lower than those in the other carcinoma tissues. No correlation was observed between the structures of Lewis glycolipids and the histological classification. The gene expression of α2,3- and α2,6-sialyltransferases and α1,3/4-fucosyltransferase for the synthesis of Lewis-active glycolipids was not positively correlated with the amounts of the respective glycolipids, probably due to the epigenetic regulation of transferases in the overall metabolic pathways for lacto-series glycolipids. However, the amounts of GM3 and GD3 with short carbohydrate chains correlated with the relative intensities of GM3 and GD3 synthase gene expression, respectively. Among ovarian carcinoma-derived cell lines, the serous cystadenocarcinoma-derived ones exhibited a lower frequency of Lewis-active glycolipid expression than the other carcinoma-derived ones, which was similar to that in the respective tissues. Thus, malignancy-related Lewis-active glycolipids were shown to be regulated in different modes in ovarian serous cystadenocarcinomas and the other carcinomas.

Original languageEnglish
Pages (from-to)1061-1066
Number of pages6
JournalOncology Letters
Volume1
Issue number6
DOIs
Publication statusPublished - 2010 Nov

Fingerprint

Glycolipids
N-Acetylneuraminic Acid
Serous Cystadenocarcinoma
Carcinoma
Sialyltransferases
galactoside 3-fucosyltransferase
Transferases
Gene Expression
Mucinous Cystadenocarcinoma
Clear Cell Adenocarcinoma
Endometrioid Carcinoma
Cell Line
Metabolic Networks and Pathways
Epigenomics
Monoclonal Antibodies
Carbohydrates
Antigens

Keywords

  • Blood group
  • Gangliosides
  • Glycolipids
  • Ovarian cancer
  • Serous cystadenocarcinoma
  • Tumor-associated antigen

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Expression of α2,6-sialic acid-containing and lewis-active glycolipids in several types of human ovarian carcinomas. / Tanaka, Kyoko; Mikami, Mikio; Aoki, Daisuke; Kiguchi, Kazushige; Ishiwata, Isamu; Iwamori, Masao.

In: Oncology Letters, Vol. 1, No. 6, 11.2010, p. 1061-1066.

Research output: Contribution to journalArticle

Tanaka, Kyoko ; Mikami, Mikio ; Aoki, Daisuke ; Kiguchi, Kazushige ; Ishiwata, Isamu ; Iwamori, Masao. / Expression of α2,6-sialic acid-containing and lewis-active glycolipids in several types of human ovarian carcinomas. In: Oncology Letters. 2010 ; Vol. 1, No. 6. pp. 1061-1066.
@article{3e4074f363364b9d82ff1da65b82fbc9,
title = "Expression of α2,6-sialic acid-containing and lewis-active glycolipids in several types of human ovarian carcinomas",
abstract = "To identify glycolipid antigens associated with histologically defined types of ovarian carcinomas, we determined the amounts of α2,6-sialyl and Lewis-active glycolipids, the specific activities of the α2,3- and α2,6-sialyltransferases, and the gene expression of sugar transferases in mucinous and serous cystadenocarcinoma, clear cell adenocarcinoma and endometrioid carcinoma tissues and cell lines derived from them. α2,6-sialyl glycolipid IV6NeuAcα-nLc4Cer detected with a newly developed monoclonal antibody, Y916, was present in 5/7 serous cystadenocarcinoma cases in relatively higher amounts than those in the other carcinoma tissues. On the other hand, the amounts of Lewis-active glycolipids in serous cystadenocarcinoma tissues were lower than those in the other carcinoma tissues. No correlation was observed between the structures of Lewis glycolipids and the histological classification. The gene expression of α2,3- and α2,6-sialyltransferases and α1,3/4-fucosyltransferase for the synthesis of Lewis-active glycolipids was not positively correlated with the amounts of the respective glycolipids, probably due to the epigenetic regulation of transferases in the overall metabolic pathways for lacto-series glycolipids. However, the amounts of GM3 and GD3 with short carbohydrate chains correlated with the relative intensities of GM3 and GD3 synthase gene expression, respectively. Among ovarian carcinoma-derived cell lines, the serous cystadenocarcinoma-derived ones exhibited a lower frequency of Lewis-active glycolipid expression than the other carcinoma-derived ones, which was similar to that in the respective tissues. Thus, malignancy-related Lewis-active glycolipids were shown to be regulated in different modes in ovarian serous cystadenocarcinomas and the other carcinomas.",
keywords = "Blood group, Gangliosides, Glycolipids, Ovarian cancer, Serous cystadenocarcinoma, Tumor-associated antigen",
author = "Kyoko Tanaka and Mikio Mikami and Daisuke Aoki and Kazushige Kiguchi and Isamu Ishiwata and Masao Iwamori",
year = "2010",
month = "11",
doi = "10.3892/ol.2010.171",
language = "English",
volume = "1",
pages = "1061--1066",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Expression of α2,6-sialic acid-containing and lewis-active glycolipids in several types of human ovarian carcinomas

AU - Tanaka, Kyoko

AU - Mikami, Mikio

AU - Aoki, Daisuke

AU - Kiguchi, Kazushige

AU - Ishiwata, Isamu

AU - Iwamori, Masao

PY - 2010/11

Y1 - 2010/11

N2 - To identify glycolipid antigens associated with histologically defined types of ovarian carcinomas, we determined the amounts of α2,6-sialyl and Lewis-active glycolipids, the specific activities of the α2,3- and α2,6-sialyltransferases, and the gene expression of sugar transferases in mucinous and serous cystadenocarcinoma, clear cell adenocarcinoma and endometrioid carcinoma tissues and cell lines derived from them. α2,6-sialyl glycolipid IV6NeuAcα-nLc4Cer detected with a newly developed monoclonal antibody, Y916, was present in 5/7 serous cystadenocarcinoma cases in relatively higher amounts than those in the other carcinoma tissues. On the other hand, the amounts of Lewis-active glycolipids in serous cystadenocarcinoma tissues were lower than those in the other carcinoma tissues. No correlation was observed between the structures of Lewis glycolipids and the histological classification. The gene expression of α2,3- and α2,6-sialyltransferases and α1,3/4-fucosyltransferase for the synthesis of Lewis-active glycolipids was not positively correlated with the amounts of the respective glycolipids, probably due to the epigenetic regulation of transferases in the overall metabolic pathways for lacto-series glycolipids. However, the amounts of GM3 and GD3 with short carbohydrate chains correlated with the relative intensities of GM3 and GD3 synthase gene expression, respectively. Among ovarian carcinoma-derived cell lines, the serous cystadenocarcinoma-derived ones exhibited a lower frequency of Lewis-active glycolipid expression than the other carcinoma-derived ones, which was similar to that in the respective tissues. Thus, malignancy-related Lewis-active glycolipids were shown to be regulated in different modes in ovarian serous cystadenocarcinomas and the other carcinomas.

AB - To identify glycolipid antigens associated with histologically defined types of ovarian carcinomas, we determined the amounts of α2,6-sialyl and Lewis-active glycolipids, the specific activities of the α2,3- and α2,6-sialyltransferases, and the gene expression of sugar transferases in mucinous and serous cystadenocarcinoma, clear cell adenocarcinoma and endometrioid carcinoma tissues and cell lines derived from them. α2,6-sialyl glycolipid IV6NeuAcα-nLc4Cer detected with a newly developed monoclonal antibody, Y916, was present in 5/7 serous cystadenocarcinoma cases in relatively higher amounts than those in the other carcinoma tissues. On the other hand, the amounts of Lewis-active glycolipids in serous cystadenocarcinoma tissues were lower than those in the other carcinoma tissues. No correlation was observed between the structures of Lewis glycolipids and the histological classification. The gene expression of α2,3- and α2,6-sialyltransferases and α1,3/4-fucosyltransferase for the synthesis of Lewis-active glycolipids was not positively correlated with the amounts of the respective glycolipids, probably due to the epigenetic regulation of transferases in the overall metabolic pathways for lacto-series glycolipids. However, the amounts of GM3 and GD3 with short carbohydrate chains correlated with the relative intensities of GM3 and GD3 synthase gene expression, respectively. Among ovarian carcinoma-derived cell lines, the serous cystadenocarcinoma-derived ones exhibited a lower frequency of Lewis-active glycolipid expression than the other carcinoma-derived ones, which was similar to that in the respective tissues. Thus, malignancy-related Lewis-active glycolipids were shown to be regulated in different modes in ovarian serous cystadenocarcinomas and the other carcinomas.

KW - Blood group

KW - Gangliosides

KW - Glycolipids

KW - Ovarian cancer

KW - Serous cystadenocarcinoma

KW - Tumor-associated antigen

UR - http://www.scopus.com/inward/record.url?scp=77957931114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957931114&partnerID=8YFLogxK

U2 - 10.3892/ol.2010.171

DO - 10.3892/ol.2010.171

M3 - Article

AN - SCOPUS:77957931114

VL - 1

SP - 1061

EP - 1066

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 6

ER -